Search

Your search keyword '"Spital, Georg"' showing total 308 results

Search Constraints

Start Over You searched for: Author "Spital, Georg" Remove constraint Author: "Spital, Georg"
308 results on '"Spital, Georg"'

Search Results

4. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

5. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

7. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

11. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

16. Faricimab Treat-and-Extend for Diabetic Macular Edema

17. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics

21. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

22. Initiale Diagnostik und Indikationsstellung zur Anti-Vascular-Endothelial Growth-Factor-Therapie bei Netzhauterkrankungen: Vergleich der Befundung durch Studienarzt versus Reading Center (ORCA/OCEAN-Studie)

25. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

31. Fotobasierte Untersuchung auf diabetische Augenveränderungen in einer deutschen Augenarztpraxis ohne direkten Arzt-Patienten-Kontakt

33. Laser Coagulation in AMD

34. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study

35. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization

36. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

38. High-Throughput Sequencing to Identify Mutations Associated with Retinal Dystrophies

39. Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study

42. Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy – The non‐interventional second year follow‐up to the PRIDE study

43. Implementing standardization in imaging-A plea for the Digital Imaging and Communication in Medicine (DICOM) standard in ophthalmology

49. Second opinion in retinal imaging

50. Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany

Catalog

Books, media, physical & digital resources